[1] Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo

[2] Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants

[3] Immunity and immunopathology to respiratory syncytial virus. The mouse model

[4] Systemic cell-mediated and antibody responses in infants with respiratory syncytial virus infections

[5] Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis

[6] Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model

[7] Respiratory syncytial virus infection in human immunodeficiency virus-infected children

[8] Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections

[9] Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection

[10] The immunologic response to infection with respiratory syncytial virus in infants

[11] Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

[12] Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

[13] The two open reading frames of the 22K mRNA of human respiratory syncytial virus: sequence comparison of antigenic subgroups A and B and expression in vitro

[14] Respiratory syncytial virus infection in anti-mu-treated mice

[15] Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life

[16] Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus

[17] Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat

[18] Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat

[19] Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity

[20] Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum

[21] Effect of malnutrition in Ecuadorian children on titers of serum antibodies to various microbial antigens

[22] Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants

[23] Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

[24] Interferon in nasal secretions from infants with viral respiratory tract infections

[25] Enzyme immunoassays for viral diseases